Triple HER2-blockade with lapatinib, trastuzumab, and pertuzumab for treatment of HER2 positive metastatic breast cancer with lymphangitic carcinomatosis: A case study
-
Published:2022-09
Issue:
Volume:7
Page:100183
-
ISSN:2666-6219
-
Container-title:Current Problems in Cancer: Case Reports
-
language:en
-
Short-container-title:Current Problems in Cancer: Case Reports
Author:
Nozawa KazukiORCID,
Takatsuka Daiki,
Endo Yuka,
Horisawa Nanae,
Ozaki Yuri,
Kataoka Ayumi,
Kotani Haruru,
Yoshimura Akiyo,
Hattori Masaya,
Sawaki Masataka,
Iwata Hiroji